Abdel Hamid M, Pammer LM, Oberparleiter S, Günther M, Amann A, Gruber RA, Mair A, Nocera FI, Ormanns S, Zimmer K, Gerner RR, Kocher F, Vorbach SM, Wolf D, Riedl JM, Huemer F, Seeber A. Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies. NPJ Precis Oncol. 2025 Apr 22;9(1):116. DOI: 10.1038/s41698-025-00892-y. DOI: 10.1038/s41698-025-00892-y
Walker GT, Gerner RR, Nuccio SP, Raffatellu M. Murine Models of Salmonella Infection. Curr Protoc. 2023 Jul;3(7):e824. doi: 10.1002/cpz1.824. DOI: 10.1002/cpz1.824
Sargun A, Gerner RR, Raffatellu M, Nolan EM. Harnessing Iron Acquisition Machinery to Target Enterobacteriaceae. J Infect Dis. 2021 Jun 16;223(12 Suppl 2):S307-S313. DOI: 10.1093/infdis/jiaa440. DOI: 10.1093/infdis/jiaa440
Gerner RR, Nuccio SP, Raffatellu M. Iron at the host-microbe interface. Mol Aspects Med. 2020 Oct;75:100895. doi: 10.1016/j.mam.2020.100895. Epub 2020 Sep 1. DOI: 10.1016/j.mam.2020.100895
Tilg H, Adolph TE, Gerner RR, Moschen AR. The Intestinal Microbiota in Colorectal Cancer. Cancer Cell. 2018 Jun 11;33(6):954-964. doi: 10.1016/j.ccell.2018.03.004. Epub 2018 Apr 12. DOI: 10.1016/j.ccell.2018.03.004
Moschen AR, Adolph TE, Gerner RR, Wieser V, Tilg H. Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation. Trends Endocrinol Metab. 2017 May;28(5):388-397. DOI: 10.1016/j.tem.2017.01.003. Epub 2017 Feb 15. DOI: 10.1016/j.tem.2017.01.003
Gerner RR, Moschen AR, Tilg H. Targeting T and B lymphocytes in inflammatory bowel diseases: lessons from clinical trials. Dig Dis. 2013;31(3-4):328-35. DOI: 10.1159/000354687. Epub 2013 Nov 14. DOI: 10.1159/000354687
Gerner RR, Wieser V, Moschen AR, Tilg H. Metabolic inflammation: role of cytokines in the crosstalk between adipose tissue and liver. Can J Physiol Pharmacol. 2013 Nov;91(11):867-72. doi: 10.1139/cjpp-2013-0050. Epub 2013 May 8. DOI: 10.1139/cjpp2013-0050